| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |